561 related articles for article (PubMed ID: 34000365)
21. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.
Yue B; Zong G; Tao R; Wei Z; Lu Y
Phytother Res; 2022 Nov; 36(11):4125-4138. PubMed ID: 36100366
[TBL] [Abstract][Full Text] [Related]
22. Effect of traditional Chinese medicine on metabolism disturbance in ischemic heart diseases.
Wang A; Song Q; Li Y; Fang H; Ma X; Li Y; Wei B; Pan C
J Ethnopharmacol; 2024 Jul; 329():118143. PubMed ID: 38583735
[TBL] [Abstract][Full Text] [Related]
23. Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus.
Su M; Hu R; Tang T; Tang W; Huang C
Front Endocrinol (Lausanne); 2022; 13():1085092. PubMed ID: 36760813
[TBL] [Abstract][Full Text] [Related]
24. Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats.
Liu D; Lin L; Lin Y; Zhong Y; Zhang S; Liu W; Zou B; Liao Q; Xie Z
Biomed Pharmacother; 2019 Jan; 109():1361-1371. PubMed ID: 30551387
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease.
Cheng TY; Li JX; Chen JY; Chen PY; Ma LR; Zhang GL; Yan PY
Chin Med; 2021 Oct; 16(1):108. PubMed ID: 34686199
[TBL] [Abstract][Full Text] [Related]
26. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
27. The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.
Chen YZ; Yuan MY; Chen YL; Zhang X; Xu XT; Liu SL; Zou X; Tao JL; Qiang YH; Wu J; Sun QM
Curr Drug Targets; 2021; 22(11):1222-1231. PubMed ID: 33845736
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.
Wei L; Zhang L; Zhang Y; Yan L; Liu B; Cao Z; Zhao N; He X; Li L; Lu C
J Ethnopharmacol; 2023 Sep; 313():116381. PubMed ID: 36940735
[TBL] [Abstract][Full Text] [Related]
29. Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota.
Jia Q; Wang L; Zhang X; Ding Y; Li H; Yang Y; Zhang A; Li Y; Lv S; Zhang J
Pharmacol Res; 2020 Jan; 151():104552. PubMed ID: 31747557
[TBL] [Abstract][Full Text] [Related]
30. Role of gut microbiota in identification of novel TCM-derived active metabolites.
Lin TL; Lu CC; Lai WF; Wu TS; Lu JJ; Chen YM; Tzeng CM; Liu HT; Wei H; Lai HC
Protein Cell; 2021 May; 12(5):394-410. PubMed ID: 32929698
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
32. The activities and mechanisms of intestinal microbiota metabolites of TCM herbal ingredients could be illustrated by a strategy integrating spectrum-effects, network pharmacology, metabolomics and molecular docking analysis: Platycodin D as an example.
Zhong YH; Liang J; Qin Q; Wang YJ; Peng YM; Zhang T; Liu FY; Zhang XY; He JW; Zhang SW; Zhong GY; Huang HL; Zeng JX
Phytomedicine; 2023 Jul; 115():154831. PubMed ID: 37094423
[TBL] [Abstract][Full Text] [Related]
33. Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota.
Cao L; Ni H; Gong X; Zang Z; Chang H
Drugs; 2024 Feb; 84(2):179-202. PubMed ID: 38265546
[TBL] [Abstract][Full Text] [Related]
34. Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions.
Zhang Y; Lou JW; Kang A; Zhang Q; Zhou SK; Bao BH; Cao YD; Yao WF; Tang YP; Zhang L
J Ethnopharmacol; 2020 Mar; 249():112423. PubMed ID: 31765764
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota: A new target of traditional Chinese medicine for insomnia.
Feng W; Yang Z; Liu Y; Chen R; Song Z; Pan G; Zhang Y; Guo Z; Ding X; Chen L; Wang Y
Biomed Pharmacother; 2023 Apr; 160():114344. PubMed ID: 36738504
[TBL] [Abstract][Full Text] [Related]
36. The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.
Du Z; Wang J; Lu Y; Ma X; Wen R; Lin J; Zhou C; Song Z; Li J; Tu P; Jiang Y
Phytomedicine; 2020 Dec; 79():153322. PubMed ID: 32920286
[TBL] [Abstract][Full Text] [Related]
37. Herbal medicine and its impact on the gut microbiota in colorectal cancer.
Bu F; Tu Y; Wan Z; Tu S
Front Cell Infect Microbiol; 2023; 13():1096008. PubMed ID: 37469598
[TBL] [Abstract][Full Text] [Related]
38. Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites.
Chen S; Jiao Y; Han Y; Zhang J; Deng Y; Yu Z; Wang J; He S; Cai W; Xu J
Acta Diabetol; 2024 Apr; 61(4):393-411. PubMed ID: 38227209
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.
Zhang B; Liu K; Yang H; Jin Z; Ding Q; Zhao L
Front Cell Infect Microbiol; 2022; 12():855075. PubMed ID: 35433500
[TBL] [Abstract][Full Text] [Related]
40. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
